However, like NDRG1, patients with aggressive tumor types such as ER– and basal-like tumors expressed higher levels of NDRG2 relative to those with ER+ tumors and non-basal subtypes (p < 0.0001; Figure 6B,C). This evidence concerns the gene NDRG1 and neoplasm.